C Michael Gibson Selected Research

C Michael Gibson Research Topics

Disease

220	Myocardial Infarction 11/2022 - 01/2002
139	Hemorrhage 12/2022 - 02/2002
131	ST Elevation Myocardial Infarction 06/2022 - 03/2002
100	Thrombosis (Thrombus) 11/2022 - 07/2002
100	Acute Coronary Syndrome 06/2022 - 04/2002
51	Infarction (Infarctions) 01/2022 - 01/2002
45	Ischemia 03/2022 - 02/2002
33	Stroke (Strokes) 03/2022 - 09/2005
31	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 04/2002
27	Heart Failure 01/2021 - 03/2002
24	Atrial Fibrillation 01/2021 - 05/2005
23	Unstable Angina 05/2017 - 02/2002
19	Venous Thromboembolism 02/2020 - 03/2014
16	Non-ST Elevated Myocardial Infarction 11/2020 - 11/2002
11	Pathologic Constriction (Stenosis) 01/2016 - 02/2002
10	Coronary Artery Disease (Coronary Atherosclerosis) 01/2021 - 11/2002
10	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2020 - 04/2003
9	Inflammation (Inflammations) 06/2022 - 02/2003
9	Death (Near-Death Experience) 11/2020 - 11/2013
8	Pulmonary Embolism 11/2020 - 05/2005
8	Diabetes Mellitus 01/2020 - 10/2002
8	Venous Thrombosis (Deep-Vein Thrombosis) 12/2018 - 01/2015
7	COVID-19 01/2022 - 01/2020
7	Atherosclerosis 01/2022 - 02/2003
6	Stable Angina 11/2018 - 08/2004
6	Hypertension (High Blood Pressure) 01/2014 - 02/2003
5	Necrosis 06/2022 - 05/2005
5	Chest Pain (Chest Pains) 01/2020 - 05/2002
5	Renal Insufficiency (Renal Failure) 01/2020 - 02/2003
4	Rupture 01/2022 - 06/2003
4	Infections 12/2021 - 10/2005
4	Chronic Renal Insufficiency 12/2021 - 06/2014
4	Shock 01/2021 - 06/2002
4	Reperfusion Injury 12/2019 - 04/2013

Drug/Important Bio-Agent (IBA)

58	Clopidogrel (Plavix)FDA Link 01/2022 - 08/2004
38	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 03/2022 - 12/2002
35	Glycoproteins (Glycoprotein)IBA 08/2021 - 11/2002
29	cangrelorIBA 03/2022 - 12/2009
27	Enoxaparin (Lovenox)FDA LinkGeneric 02/2020 - 04/2002
26	Biomarkers (Surrogate Marker)IBA 06/2022 - 04/2002
25	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 12/2022 - 07/2013
25	RivaroxabanIBA 11/2019 - 05/2011
23	N(2)-(3-trifluoromethylphenyl)guanineIBA 06/2022 - 01/2002
21	Abciximab (ReoPro)FDA Link 10/2016 - 07/2003
21	Eptifibatide (Integrilin)FDA Link 04/2014 - 04/2003
19	omega-Chloroacetophenone (Mace)IBA 11/2020 - 02/2009
19	Heparin (Liquaemin)FDA LinkGeneric 07/2020 - 12/2002
19	Tirofiban (Aggrastat)FDA Link 01/2012 - 07/2002
18	AnticoagulantsIBA 01/2021 - 03/2005
17	Fibrinolytic Agents (Antithrombotic Agents)IBA 07/2020 - 10/2002
17	betrixabanIBA 02/2020 - 03/2014
16	TicagrelorIBA 03/2022 - 07/2013
16	Pharmaceutical PreparationsIBA 01/2022 - 03/2002
16	bivalirudin (Angiomax)FDA Link 01/2017 - 05/2006
15	Vitamin K FDA Link 01/2021 - 06/2012
13	Tenecteplase FDA Link 01/2020 - 04/2003
11	TroponinIBA 01/2020 - 07/2002
11	AntithrombinsIBA 01/2020 - 04/2002
10	C-Reactive ProteinIBA 06/2022 - 04/2002
10	S- (2- chloro- 1,1,2- trifluoroethyl)cysteine (CTFC)IBA 01/2020 - 04/2002
10	fibrin fragment D (D-dimer)IBA 01/2020 - 01/2015
9	Brain Natriuretic Peptide (Natrecor)FDA Link 06/2022 - 04/2002
9	Thrombin FDA Link 01/2020 - 06/2006
9	MB Form Creatine KinaseIBA 04/2016 - 01/2002
8	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022 - 10/2005
8	Factor Xa InhibitorsIBA 03/2019 - 05/2011
8	Prasugrel Hydrochloride FDA Link 01/2019 - 10/2006
8	GadoliniumIBA 08/2014 - 01/2006
7	CreatinineIBA 01/2019 - 11/2003
7	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2018 - 05/2003
7	Platelet Membrane Glycoprotein IIbIBA 02/2016 - 05/2007
6	eicosapentaenoic acid ethyl esterIBA 01/2022 - 01/2020
6	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2022 - 12/2009
6	CholesterolIBA 01/2022 - 04/2009
6	Warfarin (Coumadin)FDA LinkGeneric 11/2019 - 06/2012
6	Troponin IIBA 01/2016 - 04/2002
5	CSL112IBA 01/2022 - 10/2016
5	LipidsIBA 01/2022 - 04/2009
5	Apolipoprotein A-I (Apolipoprotein A1)IBA 01/2022 - 10/2016
5	Purinergic P2Y Receptor AntagonistsIBA 08/2020 - 12/2009
5	Platelet Membrane GlycoproteinsIBA 01/2020 - 06/2004
5	Factor Xa (Coagulation Factor Xa)IBA 01/2019 - 01/2012
4	Troponin T (Troponin T1)IBA 06/2022 - 07/2002
4	LDL CholesterolIBA 03/2022 - 12/2018
4	arginyl- 2,'6'- dimethyltyrosyl- lysyl- phenylalaninamideIBA 12/2019 - 04/2013
4	Streptokinase FDA Link 01/2018 - 12/2009
4	thienopyridineIBA 05/2015 - 11/2007

Therapy/Procedure

152	Percutaneous Coronary Intervention 06/2022 - 04/2002
145	Therapeutics 11/2022 - 02/2002
72	Stents 11/2022 - 01/2002
32	Thrombolytic Therapy 11/2012 - 10/2002
24	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2020 - 07/2002
12	Patient Readmission 11/2019 - 04/2004
10	Drug-Eluting Stents 11/2022 - 06/2003
9	Thrombectomy 10/2016 - 03/2011
6	Blood Transfusion (Blood Transfusions) 01/2018 - 06/2007
5	Drug Therapy (Chemotherapy) 01/2021 - 04/2007
4	Secondary Prevention 03/2019 - 03/2007
4	Catheters 11/2018 - 07/2002
4	Length of Stay 01/2016 - 06/2002